Vascular Pharmacology

Papers
(The TQCC of Vascular Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107111
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran106
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients55
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis52
Animal experimental models of ischemic limbs – A systematic review40
Graphical abstract TOC31
Biobanks: The unmet need in heart failure management27
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies25
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study25
Graphical abstract TOC25
Editorial Board24
Prevention of cardiovascular complications in elderly cancer patients24
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease24
Diabetic neuropathy: Molecular approach a treatment opportunity23
Editorial Board23
Diabetes and vascular disease: New therapeutic avenues21
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model21
Adipsin in the pathogenesis of cardiovascular diseases20
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets19
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis19
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes18
A random shuffle method to expand a narrow dataset: A heart failure cohort example18
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension17
Exploiting endothelial functions in bone regenerative medicine17
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration17
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction16
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension16
Graphical abstract TOC16
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease16
Circulating osteonectin predicts postural imbalance and cardiac dysfunction in heart failure15
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis15
Deleterious effects of levamisole, a cocaine adulterant, in rabbit aorta15
Targeting the Ca2+ signaling toolkit as an alternative strategy to mitigate SARS-CoV-2-induced cardiovascular adverse events14
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro14
Graphical abstract TOC14
Novel NLRP3 inflammasome inhibitors INF150 and INF195 attenuate isoproterenol-induced hypertrophy in H9c2 rat cardiac myoblast13
3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study13
Graphical abstract TOC13
Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment13
Myocardial energy balance and metabolism as causes of myocardial ischemia13
Dynamic co-culture of endothelial and smooth muscle cells as a platform for pathophysiological investigations of vascular calcifications13
Interplay between CD28 and PD-1 in T cell immunotherapy13
Corrigendum to “Non-coding RNAs regulate angiogenic processes” [Vascular pharmacology 133–134 (2020) 106778]12
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice12
Trimethylamine N-oxide (TMAO) impact on endothelial dysfunction: An in vitro study using bovine aortic endothelial cells12
Sexual dimorphism in aortic aneurysm: A review of the contributions of sex hormones and sex chromosomes11
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients11
Editorial Board11
The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension11
Inflammation and the pathogenesis of atherosclerosis11
The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis11
Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials11
Editorial Board11
Roles of endothelial and smooth muscle cell dysfunction and vasa vasorum in vasomotor disorders in ischemia with no obstructive coronary artery disease10
The influence of environmental hypoxia on the goldfish (Carassius auratus) heart: From functional responses to mitochondrial molecular mechanisms10
A treatment algorithm for ischemic cardiomyopathy10
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions10
Zinc alpha 2-glycoprotein associates with features of plaque stability in patients with carotid atherosclerosis10
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)9
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets9
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction9
Effects of simvastatin treatment on leptomeningeal collateral vessels: resistance, number and diameter9
The chemokine receptor CXCR4 and its ligand CXCL12 (SDF-1) localize to ependymal cilia in brain ventricles9
Advancements in non-invasive hyperspectral imaging: Mapping blood oxygen levels and vascular health for clinical and research applications9
Relevance of real-time analyzers to determine mitochondrial quality in endothelial cells and oxidative stress in preeclampsia9
Graphical abstract TOC9
Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice8
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid8
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis8
Plasma exosomes after PCI in non-diabetic STEMI patients fed barley beta-D-glucan-enriched pasta reduce oxidative stress-induced endothelial cell senescence8
Catestatin as a key attenuator of cardiac inflammation in hypertension: Role of macrophage immunosuppression8
Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study8
Potency of miR-144-3p in promoting abdominal aortic aneurysm progression in mice correlates with apoptosis of smooth muscle cells8
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment8
Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteries8
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human8
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques8
Immune response following transcatheter aortic valve procedure8
The selective deletion of tyrosyne hydroxylase gene in the endothelium affects cardiovascular function8
PI3KC2α: A novel key player in cardiac contractility and DOX-induced cardiotoxicity?7
Effects of mavacamten in human myocardium from hypertrophic obstructive cardiomyopathy (HOCM) patients: A comparison with disopyramide7
Amyloid-β: A potential mediator of aging-related vascular pathologies7
Editorial Board7
Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??7
From cine-MRI to computational models of blood flow within the heart7
Graphical abstract TOC7
Graphical abstract TOC7
Multi-omics identification of quantitative trait loci associated with vascular pathogenesis and diagnostic potential in chronic venous disease7
Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function7
MELAS syndrome: Insights into cardiac mechanics7
Sodium nitroprusside for advanced heart failure. A metanalysis of literature data7
Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease7
Editorial Board7
Extracellular stiffness as a determinant of cardiac dysfunction in Duchenne's muscular dystrophy: A study on human iPSC-derived cardiomyocytes7
Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning7
Is remote conditioning cardioprotection temperature dependent?7
TLR4-Myd88 pathway upregulated caveolin-1 expression contributes to coronary artery spasm7
Stay connected: The myoendothelial junction proteins in vascular function and dysfunction7
The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies7
Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm6
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms6
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage6
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging6
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling6
Graphical abstract TOC6
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death6
Beta-blockers in pulmonary arterial hypertension: Time for a second thought?6
Matrix metalloproteinases in aortic dissection6
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study6
Emerging therapies in dyslipidaemias6
Emerging role of the adaptive immunity in aortic aneurysm and dissection6
Contents continued6
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles6
Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability5
An intrinsic mechanism of metabolic resilience influences the cardiac response to stress5
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function5
LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell5
An AI and Statistical Shape Analysis combined framework to extract features in complex cardiovascular structures5
Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing5
Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats5
Understanding the pathobiology of intermediate filaments to curb acute and chronic cardiac dysfunction5
Palmitate-induced cardiac lipotoxicity is relieved by Quercetin and its novel acetylated derivative Q2 through inhibition of oxidative stress and inflammation5
Editorial Board5
Graphical abstract TOC5
Myocardin related transcription factor and galectin-3 drive lipid accumulation in human blood vessels5
Emerging effects of non-coding RNA in vascular endothelial cells during strokes5
0.23246717453003